Keji Pharmaceutical-B (02171): Data from Seckeizer®, CT071 and CT0590 will be presented at the 2024 ASH Annual Meeting

Zhitongcaijing · 10/17 00:09

According to the Zhitong Finance App, Keji Pharmaceutical-B (02171) announced that it will present clinical data of Saekaize® (Zevorkiorense injection, product number: CT053, a proprietary CAR-T product targeting BCMA), CT071 (an autologous CAR-T cell candidate product targeting GPRC5D), and CT0590 (an allogeneic CAR-T cell candidate product targeting BCMA) at the 66th Annual Meeting of the American Society of Hematology. The summary and further information will be announced after November 5, 2024 EST.